Research shows that as many as 1 in 7 women will experience depression after childbirth but that only half of those receive treatment. Among the barriers to access are a lack of awareness about the symptoms, difficulty securing the treatment and stigma around mental health issues., which will be available under the brand name Zurzuvae, for once-daily use over 14 days.
Before the approval of Zurzuvae, the only FDA-approved treatment for postpartum depression was Zulresso, an IV injection that could only be given in health-care facilities and would take as much as 60 hours to administer. The new pill, which acts similarly to the IV injection, greatly expands access because it can be easily taken at home.
For “someone with serious depression … this new medication is an absolute great step,” Monk said. But for other cases, “there’s still a terrible problem with accessing mental health care in this country, particularly when trying to use insurance to cover it.”
Source: Healthcare Press (healthcarepress.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves first pill to treat postpartum depressionZurzuvae, a pill meant to treat severe depression after giving birth, is the first of its kind to be approved by the U.S. Food and Drug Administration.
Source: FoxBusiness - 🏆 458. / 53 Read more »
FDA approves first pill specifically designed to treat postpartum depressionFDA APPROVED: Doctors say postpartum depression is a condition that can start during pregnancy with symptoms such as feelings of sadness, guilt, loss of energy and difficulty sleeping.
Source: News12 - 🏆 591. / 51 Read more »
FDA approves first postpartum depression pill in the US | CNNThe US Food and Drug Administration has approved the medication zuranolone for the treatment of major depressive disorder and severe postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression, a serious mental illness that can develop in about 1 in 7 new mothers after childbirth.
Source: CNN - 🏆 4. / 95 Read more »
FDA approves first-ever pill for postpartum depression in new mothersBiogen and Sage Therapeutics are behind the first FDA-approved pill for treating postpartum depression.
Source: MarketWatch - 🏆 3. / 97 Read more »
US FDA approves Biogen-Sage Therapeutics pill for clinical depressionThe U.S. Food and Drug Administration on Friday approved Biogen and Sage Therapeutics' oral pill for two common forms of depression, paving the way for patients to get a faster-acting therapy to treat their mood disorders.
Source: Reuters - 🏆 2. / 97 Read more »
FDA approves first postpartum depression pillFederal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Source: chicagotribune - 🏆 8. / 91 Read more »